Abstract

In children, abnormal thyroid function tests (TFTs) can present diagnostic difficulty due to the variety of clinical manifestations that may accompany them. Pediatric patients with abnormal TFTs are discussed in this article, along with their differential diagnoses and approaches to management. The most prevalent causes of pediatric hypothyroidism and hyperthyroidism, including Hashimoto’s thyroiditis and Graves’ disease, are thoroughly reviewed. Additionally, we explore other potential etiologies of abnormal TFTs in children: congenital hypothyroidism, resistance to thyroid hormone, nonthyroidal illness syndrome, medication use, iodine deficiency, and interferences with thyroid function immunoassays. In the setting of the pediatric population, diagnostic assessment and analysis of TFTs involving thyroid-stimulating hormone (TSH), free thyroxine (fT4), and free triiodothyronine (fT3) are addressed.

Keywords: Free thyroxine, free triiodothyronine, hyperthyroidism, hypothyroidism, pediatric, thyroid-stimulating hormone, thyroid function tests

Copyright and license

Copyright © 2023 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Akın Kağızmanlı G, Demir K. Interpretation, differential diagnosis, and clinical implications of abnormal thyroid function tests in children. Trends in Pediatrics. 2023;4(2):61-71. https://doi.org/10.59213/TP.2023.53215

References

  1. Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: A review. JAMA Pediatr. 2016;170:1008-19. https://doi.org/10.1001/jamapediatrics.2016.0486
  2. Gyuricsko E. The "slightly" abnormal thyroid test: What is the pediatrician to do? Curr Probl Pediatr Adolesc Health Care. 2020;50:100770. https://doi.org/10.1016/j.cppeds.2020.100770
  3. Soh SB, Aw TC. Laboratory testing in thyroid conditions - Pitfalls and clinical utility. Ann Lab Med. 2019;39:3-14. https://doi.org/10.3343/alm.2019.39.1.3
  4. Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-pituitary-thyroid axis. Compr Physiol. 2016;6:1387-428. https://doi.org/10.1002/cphy.c150027
  5. Peters C, Schoenmakers N. The Thyroid Gland In: Dattani MT, Brook CGD, editors. Brook's Clinical Pediatric Endocrinology. John Wiley & Sons; 2020:289-334. https://doi.org/10.1002/9781119152712
  6. Fekete C, Lechan RM. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr Rev. 2014;35:159-94. https://doi.org/10.1210/er.2013-1087
  7. Vitti P, Laszlo H. Thyroid Diseases Pathogenesis, Diagnosis, and Treatment. Springer International Publishing; 2018:763. https://doi.org/10.1007/978-3-319-45013-1
  8. Rivkees S, Bauer AJ. Thyroid Disorders in Children and Adolescents. In: Sperling MA, editor. Sperling Pediatric Endocrinology. Elsevier; 2020:395-425. https://doi.org/10.1016/B978-0-323-62520-3.00013-0
  9. Mendoza A, Hollenberg AN. New insights into thyroid hormone action. Pharmacol Ther. 2017;173:135-45. https://doi.org/10.1016/j.pharmthera.2017.02.012
  10. Bernal J, Guadaño-Ferraz A, Morte B. Thyroid hormone transporters-functions and clinical implications. Nat Rev Endocrinol. 2015;11:406-17. https://doi.org/10.1038/nrendo.2015.66
  11. Singh BK, Yen PM. A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms. Clin Diabetes Endocrinol. 2017;3:8. https://doi.org/10.1186/s40842-017-0046-z
  12. Erbaş İM, Demir K. The clinical spectrum of resistance to thyroid hormone alpha in children and adults. J Clin Res Pediatr Endocrinol. 2021;13:1-14. https://doi.org/10.4274/jcrpe.galenos.2020.2019.0190
  13. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8:30. https://doi.org/10.1038/s41572-022-00357-7
  14. Refetoff S, Bassett JH, Beck-Peccoz P, et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid. 2014;24:407-9. https://doi.org/10.1089/thy.2013.3393.nomen
  15. van Trotsenburg P, Stoupa A, Léger J, et al. Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021;31:387-419. https://doi.org/10.1089/thy.2020.0333
  16. Ford G, LaFranchi SH. Screening for congenital hypothyroidism: A worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28:175-87. https://doi.org/10.1016/j.beem.2013.05.008
  17. Büyükgebiz A. Newborn screening for congenital hypothyroidism. J Pediatr Endocrinol Metab. 2006;19:1291-8. https://doi.org/10.1515/jpem.2006.19.11.1291
  18. Özon A, Tekin N, Şıklar Z, et al. Neonatal effects of thyroid diseases in pregnancy and approach to the infant with increased TSH: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report. Turk Pediatri Ars. 2018;53:209-23. https://doi.org/10.5152/TurkPediatriArs.2018.01819
  19. Mengreli C, Kanaka-Gantenbein C, Girginoudis P, et al. Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab. 2010;95:4283-90. https://doi.org/10.1210/jc.2010-0057
  20. Klosinska M, Kaczynska A, Ben-Skowronek I. Congenital hypothyroidism in preterm newborns - the challenges of diagnostics and treatment: A review. Front Endocrinol (Lausanne). 2022;13:860862. https://doi.org/10.3389/fendo.2022.860862
  21. Ng SM, Turner MA, Gamble C, et al. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial. Trials. 2013;14:211. https://doi.org/10.1186/1745-6215-14-211
  22. Iijima S. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat? J Matern Fetal Neonatal Med. 2019;32:2591-97. https://doi.org/10.1080/14767058.2018.1441277
  23. Uchiyama A, Kushima R, Watanabe T, Kusuda S. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial. J Pediatr Endocrinol Metab. 2015;28:177-82. https://doi.org/10.1515/jpem-2014-0024
  24. Gök M, Deveci Sevim R, Öztürk S, Anık A. Evaluation of thyroid pathologies detected during school screening in healthy school-age children. Trends in Pediatrics. 2022;3(3):77-85. https://doi.org/10.4274/TP.2022.53825
  25. Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013;5:45-9. https://doi.org/10.4274/jcrpe.855
  26. Vanderpump MP. Epidemiology of iodine deficiency. Minerva Med. 2017;108:116-23. https://doi.org/10.23736/S0026-4806.16.04918-1
  27. Booms S, Hill E, Kulhanek L, Vredeveld J, Gregg B. Iodine deficiency and hypothyroidism from voluntary diet restrictions in the US: Case reports. Pediatrics. 2016;137:e20154003. https://doi.org/10.1542/peds.2015-4003
  28. Leung AKC, Leung AAC. Evaluation and management of the child with hypothyroidism. World J Pediatr. 2019;15:124-34. https://doi.org/10.1007/s12519-019-00230-w
  29. Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012;19:414-9. https://doi.org/10.1097/MED.0b013e3283565bb2
  30. Lee S, Farwell AP. Euthyroid sick syndrome. Compr Physiol. 2016;6:1071-80. https://doi.org/10.1002/cphy.c150017
  31. Lauffer P, Zwaveling-Soonawala N, Naafs JC, Boelen A, van Trotsenburg ASP. Diagnosis and management of central congenital hypothyroidism. Front Endocrinol (Lausanne). 2021;12:686317. https://doi.org/10.3389/fendo.2021.686317
  32. Persani L, Brabant G, Dattani M, et al. 2018 European Thyroid Association (ETA) Guidelines on the diagnosis and management of central hypothyroidism. Eur Thyroid J. 2018;7:225-37. https://doi.org/10.1159/000491388
  33. Ramos HE. Thyroid hormone cell membrane transport defect. Endocr Dev. 2014;26:108-17. https://doi.org/10.1159/000363158
  34. van Geest FS, Groeneweg S, Visser WE. Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment. Endocrine. 2021;71:689-95. https://doi.org/10.1007/s12020-020-02603-y
  35. Moran C, Schoenmakers N, Visser WE, Schoenmakers E, Agostini M, Chatterjee K. Genetic disorders of thyroid development, hormone biosynthesis and signalling. Clin Endocrinol (Oxf). 2022;97:502-14. https://doi.org/10.1111/cen.14817
  36. Dumitrescu AM, Korwutthikulrangsri M, Refetof S. Impaired sensitivity to thyroid hormone: Defects of transport, metabolism, and action. Endotext. 2015. Available at: https://www.ncbi.nlm.nih.gov/books/NBK279066/
  37. van Gucht ALM, Meima ME, Moran C, et al. Anemia in patients with resistance to thyroid hormone α: A role for thyroid hormone receptor α in human erythropoiesis. J Clin Endocrinol Metab. 2017;102:3517-25. https://doi.org/10.1210/jc.2017-00840
  38. Léger J, Carel JC. Diagnosis and management of hyperthyroidism from prenatal life to adolescence. Best Pract Res Clin Endocrinol Metab. 2018;32:373-86. https://doi.org/10.1016/j.beem.2018.03.014
  39. Léger J, Carel JC. Hyperthyroidism in childhood: Causes, when and how to treat. J Clin Res Pediatr Endocrinol. 2013;5:50-6. https://doi.org/10.4274/jcrpe.854
  40. Mokhashi MH, Desai U, Desai MP. Hyperthyroidism in children. Indian J Pediatr. 2000;67:653-6. https://doi.org/10.1007/BF02762177
  41. Mooij CF, Cheetham TD, Verburg FA, et al. 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease. Eur Thyroid J. 2022;11:e210073. https://doi.org/10.1530/ETJ-21-0073
  42. Tonacchera M, Agretti P, Rosellini V, et al. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid. 2000;10:859-63. https://doi.org/10.1089/thy.2000.10.859
  43. Demir K, Tunç S, van Mullem AA, Visser TJ. Familial hyperthyroidism associated with a novel activating TSH receptor mutation: report of five cases. Çocuk Sağlığı ve Hastalıkları Dergisi. 2015;58:23-7.
  44. Nabhan ZM, Kreher NC, Eugster EA. Hashitoxicosis in children: clinical features and natural history. J Pediatr. 2005;146:533-6. https://doi.org/10.1016/j.jpeds.2004.10.070
  45. Erdem E, Namer IJ, Saribas O, et al. Cerebral fat embolism studied with MRI and SPECT. Neuroradiology. 1993;35:199-201. https://doi.org/10.1007/BF00588493
  46. Tessaris D, Corrias A, Matarazzo P, et al. Thyroid abnormalities in children and adolescents with McCune-Albright syndrome. Horm Res Paediatr. 2012;78:151-7. https://doi.org/10.1159/000342641
  47. Celi FS, Coppotelli G, Chidakel A, et al. The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab. 2008;93:2383-9. https://doi.org/10.1210/jc.2007-2237
  48. Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab. 1999;84:4317-23. https://doi.org/10.1210/jcem.84.12.6215
  49. Hamburger JI, Hamburger SW. Diagnosis and management of large toxic multinodular goiters. J Nucl Med. 1985;26:888-92.
  50. Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: Clinical implications and detection algorithm. Endocr Rev. 2018;39:830-50. https://doi.org/10.1210/er.2018-00119
  51. Paketçi A, Köse E, Gürsoy Çalan Ö, et al. Serum level of biotin rather than the daily dosage is the main determinant of interference on thyroid function assays. Horm Res Paediatr. 2019;92:92-8. https://doi.org/10.1159/000502740
  52. Khoo S, Lyons G, McGowan A, et al. Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods. Eur J Endocrinol. 2020;182:533-8. https://doi.org/10.1530/EJE-19-1021
  53. Hennemann G, Docter R, Krenning EP, Bos G, Otten M, Visser TJ. Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein. Lancet. 1979;1:639-42. https://doi.org/10.1016/s0140-6736(79)91080-8
  54. Dieu X, Bouzamondo N, Briet C, et al. Familial dysalbuminemic hyperthyroxinemia: An underdiagnosed entity. J Clin Med. 2020;9:2105. https://doi.org/10.3390/jcm9072105
  55. Pappa T, Refetoff S. Human genetics of thyroid hormone receptor beta: Resistance to thyroid hormone beta (RTHβ). Methods Mol Biol. 2018;1801:225-40. https://doi.org/10.1007/978-1-4939-7902-8_18
  56. Persani L, Campi I. Syndromes of resistance to thyroid hormone action. Exp Suppl. 2019;111:55-84. https://doi.org/10.1007/978-3-030-25905-1_5
  57. Salerno M, Improda N, Capalbo D. Subclinical hypothyroidism in children. Eur J Endocrinol. 2020;183:13-28. https://doi.org/10.1530/EJE-20-0051
  58. Bona G, Prodam F, Monzani A. Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol. 2013;5:23-8. https://doi.org/10.4274/jcrpe.851
  59. Metwalley KA, Farghaly HS. Subclinical hypothyroidism in children: updates for pediatricians. Ann Pediatr Endocrinol Metab. 2021;26:80-5. https://doi.org/10.6065/apem.2040242.121
  60. Murillo-Vallés M, Martinez S, Aguilar-Riera C, Garcia-Martin MA, Bel-Comós J, Ybern MLG. Subclinical hypothyroidism in childhood, treatment or only follow-up? BMC Pediatr. 2020;20:282. https://doi.org/10.1186/s12887-020-02177-8
  61. Tng EL. The debate on treating subclinical hypothyroidism. Singapore Med J. 2016;57:539-45. https://doi.org/10.11622/smedj.2016165
  62. Vandendriessche B, Lapauw B, Kaufman JM, Fiers T. A practical approach towards the evaluation of aberrant thyroid function tests. Acta Clin Belg. 2020;75:155-62. https://doi.org/10.1080/17843286.2019.1577531